ORENF yields 3.81% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, ORENF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ORENF + MRK for your $10,000?
Origin Enterprises plc provides agronomy services company in Ireland, the United Kingdom, Belgium, Brazil, Poland, Romania, Ukraine, and Latin America. It develops products and services to improve soil fertility, nutrient use efficiency, and crop productivity. The company provides integrated agronomy and on-farm services comprising agronomy advice, services, and inputs directly to arable, fruit, and vegetable growers; and seed, nutrients, crop protection products and digital tools. It also offers procurement and supply chain solutions comprising prescription blended fertilizers and animal feed ingredients; and digital agronomy applications and agri-tech services to primary producers, input manufacturers, and agri-service companies. In addition, the company engages in the provision of advisory, service, and input, as well as turf and amenity management solutions to the professional sports turf, landscaping, and amenity sectors. Further, it is involved in the manufacture and distribution of landscaping, forestry, and maintenance equipment; IT implementation, maintaining, and licensing of software; grain handling; grain and feed trading; property trading; provender milling; and silo operation business. Additionally, the company provides sports and amenities; and agricultural and construction inputs. It provides its solutions under the Agrii, Goulding, Fortgreen, RHIZA, Origin Amenity Solutions, Origin Fertilisers, PB Kent, Linemark, Green-tech, and Origin Digital brand names. Origin Enterprises plc was incorporated in 2006 and is based in Dublin, Ireland.
Full ORENF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.